A comparison of PAM50 intrinsic subtyping with immunohistochemistry and clinical prognostic factors in tamoxifen-treated estrogen receptor-positive breast cancer (Q34268261)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A comparison of PAM50 intrinsic subtyping with immunohistochemistry and clinical prognostic factors in tamoxifen-treated estrogen receptor-positive breast cancer |
scientific article |
Statements
1 reference
A comparison of PAM50 intrinsic subtyping with immunohistochemistry and clinical prognostic factors in tamoxifen-treated estrogen receptor-positive breast cancer (English)
1 reference
1 reference
Maggie C U Cheang
1 reference
Elaine R Mardis
1 reference
David Voduc
1 reference
Torsten O Nielsen
1 reference
Joel S Parker
1 reference
Samuel Leung
1 reference
Tammi Vickery
1 reference
Jacqueline Snider
1 reference
Inge J Stijleman
1 reference
Jerry Reed
1 reference
Philip S Bernard
1 reference
Matthew J Ellis
1 reference
13 September 2010
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference